A Phase I clinical trial launched in 2015 to evaluate BPC-157s safety and pharmacokinetics in healthy volunteers was marked as completed but never published, with the results withdrawn without explanation (typically a red flag- if anyone has a scoop, do share!)
02 Topical product is causing irritation Community reports describe reducing frequency/concentration and avoiding strong actives
Catalog depth and proprietary blend options
Collectively, these findings support the interactions of GHK and GHK-Cu complexes with mammalian models as research tools for studying redox regulation, peptide-mediated antioxidant signaling, and oxidative stress modulation
Interstitial fluid flow in cancer: Implications for disease progression and treatment
The mechanism is scientifically sound and consistently supported by animal data, but human efficacy and safety have not been established through clinical trials